ACLY and pancreatic neoplasm: Among FA synthesis inhibitors, BAY ACC022 and SB-204990, respectively targeting the Acetyl-CoA carboxylase (ACC) and ATP citrate lyase (ACLY), reduced tumor growth in pancreatic cancer xenograft models [187,188].